PHILADELPHIA — The American Association for Cancer Research (AACR), the world’s oldest and largest cancer research organization, reiterates its support for the responsible conduct of human embryonic stem cell research that, up until this week, wa…
Regular use of ibuprofen and aspirin inhibits the formation and growth of breast cancer, according to data published in the Proceedings for the 94th Annual Meeting of the American Association for Cancer Research (AACR). The data, taken from the National Cancer Institute?s (NCI) Women?s Health Initiative (WHI) Observational Study, concluded that weekly doses of non-steroidal anti-inflammatory drugs (NSAIDs) had a significant effect in reducing the risk of breast cancer.
?These results suggest that even women at high risk for breast cancer may be protected by taking NSAIDs,? explains Randall Harris, M.D., Ph.D., lead investigator of the study, professor of the division of epidemiology and biometrics at the Ohio State University. ?However, before usage guidelines for NSAIDs can be implemented, additional studies are needed.?
Scientists at the John Wayne Cancer Institute in Santa Monica, California have found a panel of molecular markers that could signal which patients might have the best results following vaccination for malignant melanoma. According to a study published in the January 15, 2003 issue of Cancer Research, a journal of the American Association for Cancer Research (AACR), the scientists showed that patient survival improved significantly if their tumors expressed higher levels for these markers, known as melanoma-associated antigens (MAAs).